Original Source(s)
Related Content
FDA Expands Pediatric Roflumilast Use
The expanded indication is supported by pharmacokinetic, safety, tolerability, exploratory efficacy, and long-term safety data from studies in children aged 2 to 5 years.
June 30, 2026
-
3 min
FDA Permits New Sunscreen Ingredient After 20 Years
The sunscreen ingredient, which has been marketed internationally for years, is considered generally recognized as safe and effective for use in adults and pediatric patients aged 6 months and older.
June 9, 2026
-
2 min